...
首页> 外文期刊>Trials >Effect and associated factors of a clinical pharmacy model in the incidence of medication errors (EACPharModel) in the Hospital Pablo Tobón Uribe: study protocol for a stepped wedge randomized controlled trial (NCT03338725)
【24h】

Effect and associated factors of a clinical pharmacy model in the incidence of medication errors (EACPharModel) in the Hospital Pablo Tobón Uribe: study protocol for a stepped wedge randomized controlled trial (NCT03338725)

机译:临床药房模型在医院PabloTobónURIBE中临床药房模型的影响及相关因素:阶梯楔随机对照试验的研究方案(NCT03338725)

获取原文
           

摘要

BACKGROUND:According to WHO, medication error (ME) is a subject that requires attention at all levels of care to reduce severe and preventable damage related to medication use. Clinical pharmacy practice standards have been proposed around the world so that the pharmacist, as part of a multidisciplinary health team, can help improve patient safety; however, further evidence derived from adequate studies is needed to demonstrate this. This study aims to assess the effect of a clinical pharmacy practice model (CPPM) in preventing MEs associated with the medication use process.METHODS:A prospective, stepped-wedge, cluster-randomized, controlled trial with a duration of 14?months will be performed to compare the effect of a CPPM along with the usual care process of patients in the Pablo Tobón Uribe Hospital (Medellin, Colombia). The study is designed as a cluster-randomized controlled trial, involving five hospital wards (clusters) and 720 patients. Medical wards are allocated to interventions using a stepped-wedge design. Clusters are initially assigned to the control group. After a 2-month observation period, hospital clusters were randomly allocated to the intervention group. Study outcomes will be assessed at baseline and at 2, 4, 6, 8, 10, and 12?months after randomization. The primary outcome will be to assess the effect of a CPPM on the incidence of medication errors associated with the medication use process. Drug-related problems and factors that contribute to the occurrence of MEs will be assessed as secondary outcomes. Statistical analyses will be performed using a mixed model, with the treatment group and time as fixed effects and the clustering structure as a random effect. Statistical analysis will be performed using Pearson chi-square tests and Student's t-tests, and a P value ?0.05 will be considered statistically significant.DISCUSSION:As far as we know, this is the first stepped-wedge, cluster-randomized, controlled trial designed to assess the change of a CPPM on the incidence of medication errors in a hospital in Colombia, and it could generate valuable information about a standardized and patient-centered clinical pharmacy model to improve the safety of inpatient care.TRIAL REGISTRATION:ClinicalTrials.gov, NCT03338725. Registered on 9 November 2017. The first patient was randomized on 2 February 2018.PROTOCOL VERSION:0010112018JG.
机译:背景:根据世卫组织,药物错误(ME)是一个需要在各级护理中注意力,以减少与药物使用相关的严重和可预防的损害。临床药房练习标准已经在世界各地提出,使药剂师作为多学科卫生团队的一部分,可以帮助改善患者安全;然而,需要进一步源于足够研究的证据来证明这一点。本研究旨在评估临床药房实践模型(CPPM)对预防药物使用过程相关的影响的影响。方法:持续14个月的前瞻性,跨行楔,簇随机,受控试验进行了比较CPPM的效果以及PabloTobónUribe医院(Medellin,哥伦比亚)的患者常规护理过程。该研究旨在作为群集随机对照试验,涉及五个医院病房(群集)和720名患者。使用踩楔形设计分配给干预措施。群集最初分配给控制组。经过2个月的观察期后,医院群集被随机分配给干预组。研究结果将在基线和2,4,6,8,10和12月的随机化后进行评估。主要结果是评估CPPM对与药物使用过程相关的药物误差发生率的影响。与MES发生有助于发生的药物有关的问题和因素将被评估为二次结果。将使用混合模型进行统计学分析,治疗组和时间作为固定效应和聚类结构作为随机效应。统计分析将使用Pearson Chi-Square测试和学生的T检验进行,并且P值<?0.05将被视为统计学意义。讨论:据我们所知,这是第一个阶梯式楔形,群集随机性受控试验旨在评估哥伦比亚医院药物误差发病率的CPPM的变化,它可以产生有关标准化和患者为中心的临床药房模型的有价值的信息,以改善住院护理的安全性.Trial注册:临床注册:临床注册.gov,nct03338725。 2017年11月9日注册。第一员于2018年2月2日随机随机化.Protocol版本:0010112018JG。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号